The increasing prevalence of hyperuricemia, influenced by dietary changes, underscores the importance of population-based epidemiological research, particularly in regions lacking data. Beyond the well-documented complications of hyperuricemia on renal and articular fronts, elevated levels of serum uric acid are designated as a major risk factor for cardiovascular diseases, strokes, peripheral atheropathies, and renal failure. Long-standing asymptomatic hyperuricemia may pave the way for vascular and articular lesions. It is characterized by an elevation in plasma uric acid levels without clinical signs of gout, posing a therapeutic challenge due to the ambiguity surrounding the risk-benefit ratio of urate-lowering treatments (ULTs). While the necessity of treating asymptomatic hyperuricemia remains debated, the detection of urate deposits through imaging, particularly osteoarticular ultrasound, emerges as a key indicator. The ultrasound signs of uratic deposits exhibit high specificity and high positive predictive value, but a more limited sensitivity for early gout. These signs of uratic deposits primarily include the double contour sign, aggregates, and tophi. Various imaging modalities, including synovial fluid microscopy, computed tomography (CT), dual-energy computed tomography (DECT), and osteoarticular ultrasound, aid in identifying uric acid crystal deposits, with DECT emerging as an innovative method. Osteoarticular ultrasound provides a unique opportunity to better characterize individuals with hyperuricemia and gout, influencing the determination of therapeutic goals and clinical directions. Specific signs such as "double contour" and tophi, assessed by color Doppler, contribute to diagnostic precision. Osteoarticular ultrasound represents a potentially significant tool for the diagnosis, assessment, and monitoring of gout pathology, offering the possibility to decide on and evaluate treatment effectiveness. Despite its utility, the reproducibility of osteoarticular ultrasound requires thorough investigation. This tool proves crucial in the nuanced management of asymptomatic hyperuricemia, providing valuable insights into the patterns of urate crystal deposition and guiding therapeutic interventions.
Read full abstract